News | June 27, 2011

CT Angiography Improves Detection of Heart Disease in African-Americans


June 27, 2011 — Researchers may have discovered one reason that African-Americans are at increased risk for heart attacks and other cardiovascular events.

According to a new study published online in the journal Radiology, African-Americans have increased levels of non-calcified plaque, which consists of buildups of soft deposits deep in the walls of the arteries that are not detected by some cardiac tests. Non-calcified plaque is more vulnerable to rupturing and causing a blood clot, which could lead to a heart attack or other cardiovascular event.

According to the U.S. Department of Health and Human Services, African-American adults are more likely to be diagnosed with coronary heart disease and are at greater risk of death from heart disease than white adults. In 2007, African-American men were 30 percent more likely than non-Hispanic white men to die from heart disease.

“For a long time, physicians have searched for explanations as to why African-Americans have higher rates of heart disease and higher cardiac death rates, but less coronary artery calcium than Caucasians,” said U. Joseph Schoepf, M.D., professor of radiology and medicine and director of cardiovascular imaging at Medical University of South Carolina in Charleston. “We show that one possible explanation for the discrepancy may be found in the higher rate of less stable, non-calcified plaque in the heart vessels of African-Americans.”

Calcium scoring with computed tomography (CT) is a common screening tool for patients at risk for cardiovascular disease because increased levels of calcified plaque in the coronary arteries generally links to a greater risk of heart attack or other cardiovascular event. However, calcium scoring does not detect non-calcified plaque.

For the study, researchers compared 301 patients who underwent both calcium scoring with CT and contrast-enhanced coronary CT angiography (cCTA). cCTA provides a more comprehensive picture of the arteries, including the presence of non-calcified and mixed plaques.

The study group comprised 50 percent each of African-American and white patients, 33 percent of whom were male (mean age 55).

Calcium scoring revealed that calcified plaque was much more prevalent in the coronary arteries of white patients than in African-Americans (45 percent versus 26 percent). The cCTA revealed that, compared with the white patients, many more African-American patients had non-calcified plaque (64 percent versus 41 percent), and in greater amounts. The median volume of non-calcified plaque among the African-American patients was 2.2 milliliters (mL), compared with 1.4 mL among white patients.

Based on these results, the researchers suggest that the value of calcium scoring as a screening tool for African-Americans should be reexamined.

“The results of coronary artery calcium scoring studies are to be treated with caution in African-Americans, because they may not reflect the true extent of cardiovascular disease,” Dr. Schoepf said.

While cCTA does expose patients to ionizing radiation, according to Dr. Schoepf, the effective dose of this procedure has been considerably reduced over the past few years, making it a viable screening option if other prerequisites of a successful screening test are also met.

“For African-American patients, coronary CT angiography may be a more appropriate screening tool for cardiovascular risk,” he said.

For more information: http://radiology.rsna.org/


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now